The UFO Fund That Surged 160% (Procure Space)

Conspiracy theorists might be winning.. as the “UFO” & space sector is being repriced in real time. NASDAQ:UFO (the Procure Space ETF) is the clearest expression of that trade. The fund has returned more than 160% over the past twelve months, more than triple the S&P 500. To put the move in perspective: UFO was trading under $20 in May 2024. It’s near $65 today.

Daily volume was an afterthought two years ago, around 15,000 shares. It’s now regularly exceeding 1.5 million. The market has made up its mind on direction. The question now is whether the price has run ahead of the event.

Catalyst 1: SpaceX

UFO does not hold SpaceX. The company remains private. Its 54-name portfolio of satellite operators, launch infrastructure firms, and defense technology companies has become the default listed proxy for the commercial space ecosystem that SpaceX has spent a decade building.

When SpaceX goes public targeting a valuation of $1.5 to $1.75 trillion, which would be the largest IPO in history, surpassing Saudi Aramco's $29 billion raise, institutional funds historically deferred space sector allocations for years, are forced to act - or lose out on billions. UFO is where that capital has been pre-positioning.

Net inflows of $717 million over the past six months confirm the rotation is already underway. The sector as a whole attracted $1.3 billion in new capital in the past month alone, pushing total space ETF assets above $3.3 billion.

Institutional capital is starting to make a long-term structural allocation decision ahead of a landmark event.

Catalyst 2: UFOs

SpaceX is the institutional story, but there’s a parallel one running underneath, less polish but extremely real.

Every few months a government disclosure story breaks. A congressional hearing, Pentagon report, a front-page claim about recovered craft or non-human intelligence,

And the stories vary in credibility, some less reliable than others. But the market response does not, every cycle has more-and-more people, sending retail flows into the ticker literally named $UFO, regardless of how much the underlying fund has any connection to the subject matter.

The fund's mandate requires that holdings receive at least 50% of their revenues or profits from space-related businesses; the underlying index is designed as a benchmark for companies engaged in space-related business, specifically those utilizing satellite technology.

Anyone that seriously believes in UFO tech would invest in this fund, assuming it would encompass the first companies to “commercialize the tech”.

This includes billionaires like Robert Bigelow, who in 2008 won a $22 million Defense Intelligence Agency contract through his subsidiary BAASS to investigate UAP data. He purchased Skinwalker Ranch as a research site, and has said publicly that Americans are being held back from serious UAP research by what he called a 'juvenile taboo’.le taboo.'

From Joke to Asset Class: The Credibility Arc

It is worth remembering where the space sector stood three years ago. UFO itself was trading below $15, averaging 15,000 shares a day, largely ignored by institutional allocators who treated commercial space as either a government dependency or a vanity project for billionaires. The narrative around the sector was speculative at best.

What changed isn’t one thing, but a sequence of them:

Rocket Lab proved the launch business could be run like a business.

Planet Labs found that smallsat data had customers willing to pay for it

Intuitive Machines put a commercial lander on the moon.

None of these were guaranteed outcomes, and none of them happened quickly. What they did, collectively, was make the next institutional allocation decision slightly harder to defer.

And by late 2025, the sector crossed a threshold, It was no longer a thematic bet on a distant future, but an infrastructure story with revenue, contracts, and a $1.5 trillion company preparing to list. The capital rotation that followed wasn’t speculative anymore, it was delayed recognition of a sector that had already matured.

What the Fund Holds, and What It Doesn't

Top holdings include Planet Labs, Viasat, EchoStar, Rocket Lab, and Garmin — operational businesses with real revenue, not pre-revenue speculative plays. That gives the fund a P/E of roughly 17x and a modest 0.55% dividend yield, unusual for a thematic vehicle of this kind. The expense ratio of 0.75% is elevated relative to broad-market funds, which frames UFO as a theme position rather than a core allocation.

That composition also matters for understanding the fund's risk profile. UFO's heaviest holdings include names like Sirius XM and Trimble that are not pure-play space companies, meaning the fund carries operational business risk alongside thematic risk. It will not move one-for-one with SpaceX on IPO day. What it will capture is the broader institutional re-rating of the sector that a successful listing would trigger.

Traders wanting more direct SpaceX exposure have alternatives. The Tema Space Innovators ETF (NASA) holds SpaceX shares via pre-IPO secondary market transactions, with SpaceX representing over 10% of the portfolio. The ARK Space Exploration & Innovation ETF (ARKX) returned roughly 62% over the past year but has underperformed UFO year-to-date. For leveraged exposure, the 3X DFEN offers tactical access with amplified risk in both directions.

The Price Is Already Telling You Something

UFO has quadrupled in two years without the chaotic gap-and-crash structure that typically marks a retail-driven momentum trade. The rally has been orderly, steady accumulation, with rising volume and no single blow-off session. That pattern points to institutional money building a position over time rather than a crowd chasing a headline.

The extension is real though. The fund is currently trading roughly 50% above its long-term trend line, with genuine structural re-ratings that can sustain that kind of deviation for extended periods. It shows something important about what the market is already pricing in.

A significant portion of the SpaceX IPO is already at this price, and the trade isn’t a discovery play anymore, but a bet on execution which completely changes the risk profile.

That being said, a delayed timeline, valuation haircut, and macro shock pulls capital out of risk assets broadly, and the fund has a long way to revert before it finds the kind of structural support where patient money would step back in.

What a Failed IPO Actually Does

The bear case would definitely be a disappointing SpaceX listing. Whether through a lower-than-expected valuation, a delayed timeline, or a high-profile failure in the run-up. It would not just remove the primary catalyst, but it would actively reverse the institutional allocation logic that has been driving all these inflows.

Funds pre-positioned in UFO on the basis of IPO optionality would face redemption pressure simultaneously; the sector has no obvious secondary catalyst of comparable magnitude to absorb that selling.

Rocket Lab earnings, a LUNR mission landing, or a defense contract cycle cannot fill the vacuum left by a $1.5 trillion IPO that disappoints.

The asymmetry is real: the upside on a clean listing is a continued grind higher with institutional support; the downside on a failed one is a disorderly unwind from levels that are already 50% extended above the 200-day average.

It’s not a reason to avoid the trade, but a reason to size it as a high-conviction thematic position with a specific event risk attached, not a core allocation.

The Trade

The structural case is real. A $1.5 trillion IPO is a category-level event that forces allocation decisions across the institutional complex, and UFO is the most liquid pure-play vehicle to capture the sector re-rating that follows. The credibility arc of the past three years means this is not a narrative built on nothing, the underlying companies have delivered enough to justify institutional attention even without the listing.

The risk is equally clear: the fund is pricing in execution. The lean is long while the price holds above $62. The IPO is the event that either validates current levels or exposes them.

This article is for informational purposes only and does not constitute investment advice.